Helicobacter pylori seropositivity is associated with gastric cancer regardless of tumor subtype in Korea

Gut and Liver

Volumn 4, Issue 4, 2010, Pages 466-474

  Cho, Soo Jeong ^a   Choi, Il Ju ^a,c   Kim, Chan Gyoo ^a   Lee, Jong Yeul ^a   Kook, Myeong Cherl ^a   Seong, Moon Woo ^a   Park, Sook Ryun ^a   Lee, Jong Seok ^a   Kim, Young Woo ^a   Ryu, Keun Won ^a   Lee, Jun Ho ^a   Nam, Byung Ho ^b   Park, Young Iee ^a  

^a National Cancer Center   (South Korea)

^b Center for Clinical Services   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

Gastric cancer; Helicobacter pylori; Odds ratio; Prevalence; Subgroup analysis

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER CLASSIFICATION; CARDIA CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEROLOGY; SEROPREVALENCE; STOMACH CANCER; UNDIFFERENTIATED CARCINOMA;

EID: 78650671824     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2010.4.4.466     Document Type: Article

References (60)

1. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000;92:1607-1612.
2. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
3. Crespi M, Citarda F. Helicobacter pylori and gastric cancer: An overrated risk? Scand J Gastroenterol 1996;31:1041-1046.
4. Shin A, Shin HR, Kang D, Park SK, Kim CS, Yoo KY. A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer 2005;92:1273-1275.
5. Holcombe C. Helicobacter pylori: The African enigma. Gut 1992;33:429-431.
6. Singh K, Ghoshal UC. Causal role of Helicobacter pylori infection in gastric cancer: An Asian enigma. World J Gastroenterol 2006;12:1346-1351.
7. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
8. Shin HR, Won YJ, Jung KW, et al. Nationwide cancer incidence in Korea, 1999~2001: First result using the national cancer incidence database. Cancer Res Treat 2005;37:325-331.
9. Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12: 333-340.
10. Kim JH, Kim HY, Kim NY, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001;16:969-975.
11. Chang WK, Kim HY, Kim DJ, et al. Association between Helicobacter pylori infection and the risk of gastric cancer in the Korean population: Prospective case-controlled study. J Gastroenterol 2001;36:816-822.
12. Lee SA, Kang D, Shim KN, Choe JW, Hong WS, Choi H. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003;13:162-168.
13. Kim HY, Cho BD, Chang WK, et al. Helicobacter pylori infection and the risk of gastric cancer among the Korean population. J Gastroenterol Hepatol 1997;12:100-103.
14. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
15. Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-1452.
16. Limburg P, Qiao Y, Mark S, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001;93:226-233.
17. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse- type gastric adenocarcinomas. J Natl Cancer Inst 1991;83:640-643.
18. Hansson LR, Engstrand L, Nyren O, Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995;109:885-888.
19. Kato M, Asaka M, Shimizu Y, Nobuta A, Takeda H, Sugiyama T. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer. Aliment Pharmacol Ther 2004;20 Suppl 1:85-89.
20. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-1179.
21. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: Facing the enigmas. Int J Cancer 2003;106:953-960.
22. Derakhshan MH, Malekzadeh R, Watabe H, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008;57:298-305.
23. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981;11:127-139.
24. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
25. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998;1:10-24.
26. Eom HS, Kim PS, Lee JW, et al. Evaluation of four commercial enzyme immunoassay for detection of Helicobacter pylori infection. Korean J Gastroenterol 2001;37:312-318.
27. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
28. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-353.
29. Karnes WE Jr, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-174.
30. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: A meta-analysis. Am J Gastroenterol 2007;102:1789-1798. (Pubitemid 47206700)
31. Tsukuma H, Mishima T, Oshima A. Prospective study of "early" gastric cancer. Int J Cancer 1983;31:421-426.
32. Genta RM, Gurer IE, Graham DY, et al. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 1996;111: 1206-1211.
33. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-590.
34. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: Risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004;96:388-396.
35. Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad. Am J Gastroenterol 1998;93:1800-1802.
36. Lagergren J. Adenocarcinoma of oesophagus: What exactly is the size of the problem and who is at risk? Gut 2005;54 Suppl 1:i1-i5.
37. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
38. Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro- oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002;14:115-122.
39. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740.
40. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-143.
41. Tatsuta M, Iishi H, Okuda S, Taniguchi H, Yokota Y. The association of Helicobacter pylori with differentiated-type early gastric cancer. Cancer 1993;72:1841-1845.
42. Iseki K, Tatsuta M, Iishi H, Baba M, Ishiguro S. Helicobacter pylori infection in patients with early gastric cancer by the endoscopic phenol red test. Gut 1998;42: 20-23.
43. Sasazuki S, Inoue M, Iwasaki M, et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: A nested case-control study. Cancer Epidemiol Biomarkers Prev 2006;15:1341-1347.
44. Craanen ME, Blok P, Dekker W, Tytgat GN. Helicobacter pylori and early gastric cancer. Gut 1994;35:1372-1374.
45. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004;5: 133-139.
46. Nakamura T, Yao T, Niho Y, Tsuneyoshi M. A clinicopathological study in young patients with gastric carcinoma. J Surg Oncol 1999;71:214-219. (Pubitemid 29388016)
47. Lo SS, Kuo HS, Wu CW, et al. Poorer prognosis in young patients with gastric cancer? Hepatogastroenterology 1999;46:2690-2693.
48. Wang JY, Hsieh JS, Huang CJ, Huang YS, Huang TJ. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients. J Surg Oncol 1996;63:36-40.
49. Yokota T, Takahashi N, Teshima S, et al. Early gastric cancer in the young: Clinicopathological study. Aust N Z J Surg 1999;69:443-446.
50. Medina-Franco H, Heslin MJ, Cortes-Gonzalez R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: A comparative study. Ann Surg Oncol 2000;7:515-519.
51. Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK. Clinicopathologic characteristics of gastric carcinoma in elderly patients: A comparison with young patients. World J Gastroenterol 2005;11:22-26.
52. Bani-Hani KE. Clinicopathological comparison between young and old age patients with gastric adenocarcinoma. Int J Gastrointest Cancer 2005;35:43-52.
53. Kim JH, Boo YJ, Park JM, et al. Incidence and long-term outcome of young patients with gastric carcinoma according to sex: Does hormonal status affect prognosis? Arch Surg 2008;143:1062-1067.
54. Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today 1992;22:421-425.
55. Furukawa H, Iwanaga T, Hiratsuka M, et al. Gastric cancer in young adults: Growth accelerating effect of pregnancy and delivery. J Surg Oncol 1994;55:3-6.
56. Maeta M, Yamashiro H, Oka A, Tsujitani S, Ikeguchi M, Kaibara N. Gastric cancer in the young, with special reference to 14 pregnancy-associated cases: Analysis based on 2,325 consecutive cases of gastric cancer. J Surg Oncol 1995;58:191-195.
57. Lindblad M, Ye W, Rubio C, Lagergren J. Estrogen and risk of gastric cancer: A protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev 2004;13:2203-2207.
58. Romero-Gallo J, Perez-Perez GI, Novick RP, Kamath P, Norbu T, Blaser MJ. Responses of endoscopy patients in Ladakh, India, to Helicobacter pylori whole-cell and Cag A antigens. Clin Diagn Lab Immunol 2002;9:1313-1317.
59. Chang YW, Han YS, Lee DK, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 2002;101:469-474.
60. Klaamas K, Held M, Wadstrom T, Lipping A, Kurtenkov O. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 1996;67:1-5.